Table S2 from MYLK-AS1 Enhances Glutamine Metabolism to Promote EGFR Inhibitor Resistance in Non–Small Cell Lung Cancer
Year: 2025
Type: other
Abstract: Correlation between MYLK-AS1 expression and clinicopathological characteristics of 50 NSCLC patients.
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4413446130
